[Analysis of the relationship between p53 gene mutation and clinical pathophysiological characteristics of primary non-small cell lung cancer].
To investigate the significance of p53 gene mutations in non-small cell lung cancer, with focusing on the four highly conserved regions of the p53 gene. Point mutations of the p53 gene were detected in 40 lung cancer tissues and 8 benign pulmonary lesions as control by polymerase chain reaction-single strand conformation polymorphism ( PCR-SSCP) analysis. Mutations of the p53 gene were found in 19 of 40 lung cancer samples ( 47. 5%) . The frequency of the p53 gene mutations varied among the different stage ( stage I + II vs stage III + IV was 22. 2% vs 68. 2% , P < 0. 005) , and lymph node netastasis status (N1-2 vs N0 was 57. 1% vs 16. 7%, P < 0. 025) of non-small cell lung cancers. The results suggest that p53 gene mutations may be associated with the carcinogenesis and progression of non-small cell lung cancer.